The US FDA’s Dr. Harpreet Singh talks with ILCN about what the increasing use of AI means for the agency as it works to ensure drugs and devices are safe and effective. Read more
In light of data from FLAURA2 and MARIPOSA, Drs. Suresh Ramalingam and Joshua Sabari weighed the pros and cons during the 2024 TTLC meeting. Read more
During a recent debate, Drs. Anne Chiang and Stephen Liu offered differing perspectives on the feasibility of biomarker use in the small-cell lung cancer space. Read more
In an interview with ILCN, Dr. Carolyn Presley discusses combating malnourishment in vulnerable populations and the role of the microbiome in immunotherapy efficacy. Read more
Dr. Mark Kris, who leads the IASLC Pathologic Response Project, recently provided an update on efforts to collect data to confirm whether pathologic complete response can predict long-term outcomes. Read more
Drs. Sara Ghandehari and Weijia Chua discuss how to best monitor patients when guidelines and protocols vary and more research is needed. Read more
Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions
+more
In part 2 of our look at AI’s impact on radiotherapy, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, discuss how AI may be leveraged when delivering radiotherapy, including improving our ability to predict treatment response and adverse events. Read more
Artificial Intelligence in Thoracic Radiation Oncology: Patient Evaluation and Treatment Planning
+more
In part 1 of a 2-part article, Grace Lee, MD, Fridolin Haugg, MSc, and Raymond H. Mak, MD, explore the possibilities and limitations of AI applications. Read more
In an interview with ILCN, Drs. Puneeth Iyengar and Matthias Guckenberger said despite a lack of phase III data in this space, science-based recommendations are needed to optimize multimodal therapy. Read more
Dr. Narjust Florez, who is spearheading the effort at Dana Farber, says the need for research on cancer therapies for pregnant patients is urgent as both maternal age and the number of young lung cancer diagnoses are increasing. Read more